Insulin-resistant, dysfunctional adipose tissue disrupts this crucial glucose–lipid (FFA) energy transition, causing metabolic inflexibility, a hallmark of insulin-resistant states such as obesity, metabolically associated fatty liver disease (MAFLD), and type 2 diabetes. Here, INS is linked to obesity disorder.